QuickView for PLA2G16;jsessionid=DE4E0C148F45692259CEDA63456D514B;jsessionid=1F90A47A3463DDDF8FE9258495AD3843;jsessionid=1A52F6E92436D4930E3730CBA709513A;jsessionid=71A0C6D5443B5A130E5185C009E0352D;jsessionid=008D62479003D17B2146BAAD12D2168B (gene)

1. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant prog…
2. Transdermal Delivery of Adipocyte Phospholipase A2 siRNA using Microneedles to Treat Thyroid Associa…
3. Bypassing pan-enterovirus host factor PLA2G16.
4. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
5. High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer.

There were no clinical trials for PLA2G16;jsessionid=DE4E0C148F45692259CEDA63456D514B;jsessionid=1F90A47A3463DDDF8FE9258495AD3843;jsessionid=1A52F6E92436D4930E3730CBA709513A;jsessionid=71A0C6D5443B5A130E5185C009E0352D;jsessionid=008D62479003D17B2146BAAD12D2168B